INCR InterCure Ltd.: Utang jangka cendhak perusahaan

InterCure Ltd. dominates the Israeli medical cannabis sector, generating steady revenue through its own pharmacy network. The company is scaling its European presence by optimizing internal costs. Growth is driven by global partnerships and the decriminalization trend. The amount of short-term financial debt helps assess the risk of cash flow gaps, with the 0.02 mark serving as a current indicator of current liabilities.

Short-term debts measure a business's liquid margin of safety, determining its ability to settle obligations with a horizon of up to one year without the risk of default. By analyzing the current level of short-term debt, an investor assesses the financial stability of InterCure Ltd. (INCR) during a period of aggressive expansion of its European pharmacy network and medical cannabis distribution, where the balance of borrowings critically impacts the pace of global expansion.